Novel peptide inhibitors for the treatment of malignant melanoma
Malignant melanoma is characterized by aggressive local growth and early formation of metastasis. The Melanoma Inhibitory Activity (MIA) protein is known to promote invasion of melanoma cells into healthy tissue and triggers formation of metastases. After determining the functional state of MIA, the inventors of the University of Regensburg (Germany) have identi ed several peptides which inhibit MIA protein functional activity and strongly reduce the formation of metastases in vivo. These inhibitors may offer a novel treatment strategy in preventing or reducing of formation of metastases in malignant melanoma.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Reconstructing plesiosaur swimming styles with bio-mimetic control
A research group may have unraveled the mystery behind the locomotion of the ancient marine reptile, the plesiosaur, by recreating a bio-inspired control system that accounts for motion adjustment. Extinct…
Kagome breaks the rules at record breaking temperatures
In case you’re scratching your head, we help break it down. Using muon spin rotation at the Swiss Muon Source SmS, researchers at PSI have discovered that a quantum phenomenon…
New findings on heart failure
Dysferlin protein protects and shapes the membrane of heart muscle cells. Researchers from the Heart Center of the University Medical Center Göttingen (UMG) led by Priv.-Doz. Dr Sören Brandenburg have…